Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase

European Journal of Biochemistry

Volumn 262, Issue 3, 1999, Pages 907-914

  Shimada, Taketoshi ^c   Nakamura, Hiroyuki ^a   Ohuchi, Eiko ^b   Fujii, Yutaka ^c   Murakami, Yasushi ^c   Sato, Hiroshi ^c   Seiki, Motoharu ^c   Okada, Yasunori ^a  

^a KEIO UNIVERSITY   (Japan)

^b FUJI CHEMICAL INDUSTRIES LTD   (Japan)

^c NONE

Author keywords

Degradation of matrix macromolecules; Gelatinase A; Inhibition by tissue inhibitors of metalloproteinases; Membrane type 1 matrix metalloproteinase; Membrane type 3 matrix metalloproteinase

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; COLLAGEN TYPE 3; FIBRONECTIN; GELATIN; LAMININ; PROTEOGLYCAN; RECOMBINANT ENZYME; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFERRIN; VITRONECTIN;

AMINO TERMINAL SEQUENCE; ARTICLE; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME PURIFICATION; ENZYME STRUCTURE; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; PRIORITY JOURNAL;

COLLAGEN; ENZYME ACTIVATION; ENZYME PRECURSORS; GELATINASES; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; RECOMBINANT PROTEINS; SEQUENCE DELETION; SUBSTRATE SPECIFICITY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 0033564010     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00459.x     Document Type: Article

References (45)

1. 1. Stetler-Stevenson, W.G., Aznavoorian, S. & Liotta, L.A. (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9, 541-573.
2. 2. Nagase, H. & Okada, Y. (1997) Proteinases and matrix degradation. In Textbook of Rheumatology (Kelley, W.N., Harris, E.D. Jr, Ruddy, S. & Sledge, C.B., eds) pp. 323-341. W.B. Saunders & Co., Philadelphia, USA.
3. 3. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. & Seiki, M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61-65.
4. 4. Will, H. & Hinzmann, B. (1995) cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem. 231, 602-608.
5. 5. Takino, T., Sato, H., Shinagawa, A. & Seiki, M. (1995) Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J. Biol. Chem. 270, 23013-23020.
6. 6. Puente, X.S., Pendás, A.M., Llano, E., Velasco, G. & López-Otín, C. (1996) Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res. 56, 944-949.
7. 7. Butler, G.S., Will, H., Atkinson, S.J. & Murphy, G. (1997) Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases. Eur. J. Biochem. 244, 653-657.
8. 8. Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M. & Okada, Y. (1997) Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272, 2446-2451.
9. 9. Pei, D. & Weiss, S.J. (1996) Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271, 9135-9140.
10. 10. D'Ortho, M.P., Will, H., Atkinson, S., Butler, G., Messent, A., Gavrilovic, J., Smith, B., Timpl, R., Zardi, L. & Murphy, G. (1997) Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem. 250, 751-757.
11. 11. Shofuda, K., Yasumitsu, H., Nishihashi, A., Miki, K. & Miyazaki, K. (1997) Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPS with and without transmembrane domain. J. Biol. Chem. 272, 9749-9754.
12. 12. Matsumoto, S., Katoh, M., Saito, S., Watanabe, T. & Masuho, Y. (1997) Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA. Biochim. Biophys. Acta. 1354, 159-170.
13. 13. Okada, Y., Morodomi, T., Enghild, J.J., Suzuki, K., Yasui, A., Nakanishi, I., Salvesen, G. & Nagase, H. (1990) Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur. J. Biochem. 194, 721-730.
14. 14. Hayakawa, T., Yamashita, K., Ohuchi, E. & Shinagawa, A. (1994) Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J. Cell. Sci. 107, 2373-2379.
15. 15. Apte, S.S., Olsen, B.R. & Murphy, G. (1995) The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J. Biol. Chem. 270, 14313-14318.
16. 16. Kleinman, H.K., McGarvey, M.L., Liotta, L.A., Robey, P.G., Tryggvason, K. & Matrin, G.R. (1982) Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21, 6188-6193.
17. 17. Yurchenco, P.D. & Furthmayr, H. (1984) Self-assembly of basement membrane collagen. Biochemistry 23, 1839-1850.
18. 18. Minamoto, T., Ooi, A., Okada, Y., Mai, M., Nagai, Y. & Nakanishi, I. (1988) Desmoplastic reaction of gastric carcinoma: a light-and electron-microscopic immunohistochemical analysis using collagen type-specific antibodies. Hum. Pathol. 19, 815-821.
19. 19. Odermatt, E., Risteli, J., van Delden, V. & Timpl, R. (1983) Structural diversity and domain composition of a unique collagenous fragment (intima collagen) obtained from human placenta. Biochem. J. 211, 295-302.
20. 20. Ruoslahti, E. & Engvall, E. (1978) Immunochemical and collagen-binding properties of fibronectin. Ann. N.Y. Acad. Sci. 312, 178-191.
21. 21. Nagase, H. & Woessner, J.F. Jr (1980) An improved assay for proteases and polysaccharidases employing a cartilage protcoglycan substrate entrapped in polyacrylamide particles. Anal. Biochem. 107, 385-392.
22. 22. Brizzard, B.L., Chubet, R.G. & Vizard, D.L. (1994) Immunoaffinity purification of FLAG epitope-tagged bacterial alkaline phosphatase using a novel monoclonalantibody and peptide elution. Biotechniques 16, 730-735.
23. 23. Okada, Y., Gonoji, Y., Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K. & Hayakawa, T. (1992) Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J. Biol. Chem. 267, 21712-21719.
24. 24. Knight, C.G., Willenbrock, F. & Murphy, G. (1992) A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 296, 263-266.
25. 25. Murphy, G. & Willenbrock, F. (1995) Tissue inhibitors of matrix metalloendopeptidases. Meth Enzymol. 248, 496-510.
26. 26. Welgus, H.G., Jeffrey, J.J. & Eisen, A.Z. (1981) The collagen substrate specificity of human skin fibroblast collagenase. J. Biol. Chem. 256, 9511-9515.
27. 27. Banda, M. & j. Werb, Z. (1987) Elastin degradation. Meth Enzymol. 144, 288-305.
28. 28. Kuivaniemi, H., Tromp, G., Chu, M. & Prockop, D.J. (1988) Structure of a full-length cDNA clone for the prepro α2(I) chain of human type I procollagen. Comparison with the chicken gene confirms unusual patterns of gene conservation. Biochem. J. 252, 633-640.
29. 29. Miller, E.J., Finchi, J.E. Jr, Chung, E. & Butler, W.T. (1976) Specific cleavage of the native type III collagen molecule with trypsin. Similarity of the cleavage products of collagenase-produced fragments and primary structure at the cleavage site. Arch. Biochem. Biophys. 173, 631-637.
30. 30. Ala-kokko, L., Kontusaari, S., Baldwin, C.T., Kuivaniemi, H. & Prockop, D.J. (1989) Structure of cDNA clones coding for the entire prepro α1(III) chain of human type III procollagen. Differences in protein structure from type I procollagen and conservation of codon preferences. Biochem. J. 260, 509-516.
31. 31. Chiodo, A.A., Hockey, A. & Cole, W.G. (1992) A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII. J. Biol. Chem. 267, 6361-6369.
32. 32. Knäuper, V., Cowell, S., Smith, B., López-Otín, C., O'Shea, M., Morris, H., Zardi, L. & Murphy, G. (1997) The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J. Biol. Chem. 272, 7608-7616.
33. 33. Hasty, K.A., Jeffrey, J.J., Hibbs, M.S. & Welgus, H.G. (1987) The collagen substrate specificity of human neutrophil collagenase. J. Biol. Chem. 262, 10048-10052.
34. 34. Mallya, S.K., Mookhtiar, K.A., Gao, Y., Brew, K., Dioszegi, M., Birkedal-Hansen, H. & Van Wart, H.E. (1990) Characterization of 58-kilodalton human neutrophil collagenase: comparison with human fibroblast collagenase. Biochemistry 29, 10628-10634.
35. 2-terminal portion of the smaller fragment released from both collagens. Biochemistry 15, 787-792.
36. 36. Seyer, J.M. & Kang, A.H. (1981) Covalent structure of collagen: amino acid sequence of α1(III)-CB9 from type III collagen of human liver. Biochemistry 20, 2621-2627.
37. 37. Mitchel, P.G., Magna, H.A., Reeves, L.M., Lopresti-Morrow, L.L., Yocum, S.A., Rosner, P.J., Geoghegan, K.F. & Hamber, J.E. (1996) Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97, 761-768.
38. 38. Will, H., Atkinson, S.J., Butler, G.S., Smith, B. & Murphy, G. (1996) The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J. Biol. Chem. 271, 17119-17123.
39. 39. Butler, G.S., Butler, M.J., Atkinson, S.J., Will, H., Tamura, T., van Westrum, S.S., Crabbe, T., Clements, J., D'Ortho, M.P. & Murphy, G. (1998) The TIMP2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A. A kinetic study. J. Biol. Chem. 273, 871-880.
40. 40. Kinoshita, T., Sato, H., Okada, A., Ohuchi, E., Imai, K., Okada, Y. & Seiki, M. (1998) TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J. Biol. Chem. 273, 16098-16103.
41. 41. Nomura, H., Sato, H., Seiki, M., Mai, M. & Okada, Y. (1995) Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res. 55, 3263-3266.
42. 42. Tokuraku, M., Sato, H., Murukami, S., Okada, Y., Watanabe, Y. & Seiki, M. (1995) Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int. J. Cancer 64, 355-359.
43. 43. Ueno, H., Nakamura, H., Inoue, M., Imai, K., Noguchi, M., Sato, H., Seiki, M. & Okada, Y. (1997) Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res. 57, 2055-2060.
44. 44. Nakamura, H., Ueno, H., Yamashita, K., Shimada, T., Yamamoto, E., Noguchi, M., Fujimoto, N., Sato, H., Seiki, M. & Okada, Y. (1999) Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Cancer Res. 59, 467-473.
45. 45. Nakada, M., Nakamura, H., Ikeda, E., Fujimoto, N., Yamashita, J., Sato, H., Seiki, M. & Okada, Y. (1999) Expression and tissue localization of membrane-type 1, 2, 3 matrix metalloproteinases in human astrocytic tumors. Am. J. Pathol. 154, 417-428.